Navigation Links
Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
Date:12/7/2007

reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

This communication may be deemed to be solicitation material in respect of the proposed merger of AVANT and Celldex. In connection with the proposed merger, AVANT and Celldex intend to file relevant materials with the SEC, including AVANT's joint registration statement/proxy statement on Form S-4. SHAREHOLDERS OF AVANT ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING AVANT'S PROXY STATEMENT, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents free of charge at the SEC's web site, http://www.sec.gov, and AVANT shareholders will receive information at an appropriate time on how to obtain transaction-related documents for free from AVANT. Such documents are not currently available. Participants in the Solicitation The directors and executive officers of AVANT and Celldex may be deemed to be participants in the solicitation of proxies from the holders of AVANT common stock in respect of the proposed transaction. Information about the directors and executive officers of AVANT is set forth in the proxy statement for AVANT's most recent 10-K, which was filed with the SEC on March 16, 2007. Investors may obtain additional information regarding the interest of AVANT and its directors and executive officers, and Celldex and its directors and executive officers in the proposed transaction by reading the proxy statement regarding the acquisition when it becomes available.


'/>"/>
SOURCE Celldex Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... MUMBAI , August 20, 2014 ... owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), ... studies of a novel clinical development candidate, GBR ... discovered and developed by the Glenmark Biologics Research ... . GBR 1302 is based on Glenmark,s ...
(Date:8/19/2014)... , Aug. 19, 2014  The Alabama Supreme Court, in ... can sue drug makers who mislead doctors into believing that ... The case is Weeks v. Wyeth, and the decision came ... that same case last year. Heninger Garrison Davis attorneys ... patient in the case, Danny Weeks . ...
Breaking Medicine Technology:Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
... 6, 2011 Actavis, an international generic pharmaceuticals ... approval from the US Food & Drug Administration ... mg CIV.  Distribution of the product has commenced. ... to launch Zolpidem Tartrate Extended-Release Tablets 6.25 mg strength ...
... June 6, 2011 Brainlab announced today ... acquire Voyant Health. Voyant Health,s core technology, ... and to plan and digitally template surgical procedures from ... the operating room (OR). Another key technology is VoyantLink™, ...
Cached Medicine Technology:Actavis Receives FDA Approval of Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV in the U.S. 2Brainlab Acquires Voyant Health 2Brainlab Acquires Voyant Health 3
(Date:8/20/2014)... August 21, 2014 Recently, UWDress.com, the ... new selection of birthday party dresses for girls ... items are well-designed and exquisitely handmade by experienced specialists. ... 58 percent off. , The company’s new items come ... gowns, short knee length frocks, long elegant backless gowns ...
(Date:8/20/2014)... iFitDress.com, the well-known wedding dress manufacturer and retailer, has ... gowns . All items in the fresh collection are ... , iFitDress.com is among the hardest working suppliers ... to help clients worldwide to keep pace with the ... professional. According to its development manager, all its products ...
(Date:8/20/2014)... Top10BestSEOHosting.com is a website dedicated ... products. It is headed by a team of ... offers research-based information and factual studies about the ... current market. , Recently, Top10BestSEOHosting.com has compared ... GoDaddy and Bluehost are the most recommended ...
(Date:8/20/2014)... Angeles, CA (PRWEB) August 20, 2014 An ... “How to Keep Skin Looking Young at Every ... all ages maintain healthy skin . These recommendations ... age specific suggestions for women ages 25-45 and beyond. The ... and women of any age and includes using sunscreen religiously, ...
(Date:8/20/2014)... Park, Florida (PRWEB) August 20, 2014 ... over by Dr. Michael A. Sherman, a top graduate ... recently improved upon the value of its website through ... Located in the News section of parkavenuedentalfl.com, the blog ... from mere “fluff” or “filler” material, instead concentrating on ...
Breaking Medicine News(10 mins):Health News:Cheap Birthday Party Dresses for Girls Now Available at UWDress.com 2Health News:iFitDress.com Releases a New Range of Cheap Evening Gowns 2Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:Simon Ourian, Kim Kardashian’s Doctor, On Healthy Skin Suggestions for Every Age 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 3
... researchers from the University of California, they have observed that ... for developing Osteoarthritis. Osteoarthritis is a tissue change in the ... percent to 30 percent of adults over 40 years old. ... or older suffer from osteoarthritis. They conducted a study to ...
... study a clot-buster injection may unclog a mechanical heart ... researcher from University Hospital in Germany,// felt that this ... for heart failure patients who receive left ventricular assist ... mechanical pump-like device that is surgically implanted to maintain ...
... at the American Urological Association,k overweight men are more ... 40% of 1980 men surveyed between the ages of ... These men also were more likely to be older, ... Men with a waistline measuring 40 inches were nearly ...
... the United States smoking is the leading preventable cause ... people from smoking. A new study finds the more ... to start smoking. //The risk of disease increases the ... million adolescents smoke and that number has been increasing ...
... one crore documentation based care (DBC) centre project in Chennai ... first of its kind in the country. Dr Pratap Reddy, ... revolutionary concept resulting from over 25 years of international research, ... Finland who has already set up 55 such centres across ...
... Lung cancer can be effectively controlled with a higher ... for lung cancer involves a daily dose of radiotherapy five ... been found from a more intensive programme known as CHART ... researchers at the Mount Vernon Hospital, Middlesex, England, have taken ...
Cached Medicine News:
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips....
... ideal for applications such as vasectomy ... , ,The autoclavable handpiece with six-foot ... thermal cautery electrodes, allowing the physician ... a wide variety of procedures., ,The ...
Non-Cantilevered Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring diameter approximately 3.0 mm....
... for users of "completely-in-the-canal" (CIC) instruments ... - must send eartip., ,Impressions ... ,Westone custom products for the ... network of hearing healthcare providers. These ...
Medicine Products: